VectivBio Holding AG
VECT
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.06B
Close$
Share Statistics
| Market cap | $1.06 Billion |
|---|---|
| Enterprise Value | $1.06 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.12 |
| Beta | 0.1 |
| Outstanding Shares | 44,126,733 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -7.94 |
|---|---|
| PEG | -25.68 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1567.36 |
| Enterprise Value to EBIT | -11.3 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About VectivBio Holding AG
VectivBio is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions with high unmet medical need. The company is committed to pursuin...